Home / Generics

Generics

News

EMA approval for tacrolimus generic posted 10/11/2017

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) announced on 12 October 2017 that...

Lupin launches generic pain-relief med in US posted 31/10/2017

India-based generics manufacturer Lupin Pharmaceuticals (Lupin) announced on 10 October 2017 that it had launched a generic v...

FDA approves lidocaine ointment generic from Vitruvias Therapeutics posted 13/10/2017

US-based generics maker Vitruvias Therapeutics (Vitruvias) announced on 29 September 2017 that it had received approval of a...

Indivior to appeal US ruling on opioid addiction patent posted 22/09/2017

UK-based addiction treatment manufacturer Indivior Plc have announced plans to appeal against a US court, which ruled that In...

Mylan launches three HIV generics in Canada posted 22/09/2017

US generics giant Mylan Pharmaceuticals (Mylan) announced on 10 August 2017 that it had launched three generic HIV drugs in C...

 

Research

Mergers could be causing price increases for generics posted 14/11/2017

How mergers and acquisitions in the generics sector can be a factor in drug shortages and increasing prices was a question ad...

New use for old generic could treat rare cardiovascular condition posted 14/11/2017

Researchers from Canada and the UK may have found a new use for an old generic drug: treatment of the rare cardiovascular con...

Perceptions of generic drugs in Latin America: a Guatemalan case study posted 27/10/2017

A recent assessment of generic drug use in Guatemala [1] revealed a widespread lack of trust in generics, due to a combinatio...

Challenges in the rediscovery of old generics posted 13/10/2017

Finding new treatment options by repurposing generics is a cost-effective and time-efficient way of finding a new purpose for...

Repurposing thioguanine posted 13/10/2017

Repurposing and re-registering old generics is a cost-effective and time-efficient way of finding new purposes for existing d...

 

General

Kenya needs to increase use of generics to combat rising costs posted 17/11/2017

Kenyan medical insurance management firms are advising that they will only pay for generics and not brand-name prescriptions.

Texan judge invalidates Restasis patents posted 03/11/2017

On 16 October 2017, a federal judge in Texas invalidated four key patents for Allergen’s dry eye drug Restasis (cyclosporine...

FDA trying to reduce hurdles for complex generics posted 20/10/2017

Although US Food and Drug Administration (FDA) Commissioner Dr Scott Gottlieb admits that ‘FDA doesn’t control drug pricing’,...

US tribal patent deal could prevent generics posted 06/10/2017

A deal made between Allergan and a native American tribe could potentially protect the company from challenges on its dry eye...

FDA forms working group to increase generics competition posted 22/09/2017

US Food and Drug Administration (FDA) Commissioner Dr Scott Gottlieb had announced the creation of a working group of senior...